CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 100 enrolled
Drug / intervention
High CPB flowprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04084301
NCT04084301N/ACompleted

Impact of Cardiopulmonary Bypass Flow on Renal Oxygenation, Blood Flow and Tubular Injury

Sahlgrenska University Hospital·interventional·Posted Sep 10, 2019·Updated Nov 22, 2023

In Brief

A clinical study evaluating High CPB flow for Extracorporeal Circulation; Complications and 6 related conditions. Completed, enrolled 100 participants across 1 site.

Detailed Summary

During open cardiac surgery, cardiopulmonary bypass (CPB) is used to temporarily replace the function of the heart and lungs. Renal ischemia resulting in acute kidney injury is common after cardiac surgery. The renal oxygenation is impaired during CPB, but the oxygenation may be improved by increasing the CPB blood flow. In this randomized study, two CPB flow rates will be compared regarding renal outcome (biomarkers and renal oxygenation/renal blood flow), as well as markers of inflammation and hemolysis. Additionally, urine oxygen tension will be measured during CPB and the early intensive care phase and compared to renal oxygenation. Regional oxygen saturation assessed with near infrared spectroscopy from the brain and kidneys will be monitored during and after surgery.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesSweden
Collaborators--

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedSep 10, 2019
Enrollment StartSep 27, 2019
Primary CompletionNov 1, 2023
TodayJul 2, 2026
Enrollment to primary: 4.1 yearsPosted 6.8 years ago

Interventions

High CPB flowprocedure

Target CPB flow 2.9 L/min/m2 throughout the CPB period